The University of Queensland Diamantina Institute was established in 2007 as the sixth research institute of The University of Queensland. The aim of the Institute is to develop a better understanding of the molecular and cellular basis of disease, and to translate that understanding into practical outcomes for patients. Based at the Translational Research Institute (TRI) at the Princess Alexandra Hospital teaching campus in Brisbane, the Institute has almost 270 researchers and students who work closely with clinicians in the areas of cancer, immunology and genomic medicine.
The successful appointee will develop and lead an internationally competitive research group focused on cancer genetics. The researcher will be expected to engage and lead collaborative research with other members of UQDI in the cancer and genomics programmes, the Faculty/School, TRI and PA hospital campus in general to ensure maximum opportunities for research outcome translation to the clinic. They will be required to supervise and mentor post-doctoral fellows, doctoral, masters and honours students.
Applicants should possess a PhD in bioinformatics, genetics, biology, a relevant area of computer science or applied mathematics. The successful applicant will have substantial experience in the generation and analysis of next generation sequencing data from cancerous tissues, and will be an expert in bioinformatics, applied statistics or both. Experience in the analysis of blood or skin cancers would be an advantage but is not essential. Applicants must also demonstrate the ability to lead and collaborate in multi-discipline projects, and possess strong communication and time management skills.
To discuss this role please contact Professor David Evans on +61 7 3443 7051 or at firstname.lastname@example.org.